This episode tackles a question that matters in daily practice but is rarely answered cleanly: what actually happens with electrotherapy over the long term? Not after a week – but after a full year.

To explore it, we look at two brand-new scientific papers from 2026. One goes deep into the single cell; the other follows real patients across twelve months. Together they paint a surprisingly clear picture: short-term, a lot looks the same – the decisive difference only emerges over time.

We break down the difference between TENS and microcurrent (MENS), why one dampens the pain signal via the nerve while the other works a level deeper at the cell, and what that could mean for long-term tissue regeneration.

In this episode:

• TENS and microcurrent – how they fundamentally differ
• Study 1: how microcurrent dials down the "master switch" of inflammation at the cellular level
• Study 2: a 12-month head-to-head of microcurrent and TENS at the shoulder
• The "clinico-radiological paradox" – when symptoms and tissue structure move in opposite directions
• Why the real benefit often only shows up months later
• What this means for the interplay of exercise therapy and microcurrent

Sources for this episode:

Wang, Z.-L., Li, H.-B., & Li, Y.-T. (2026). Combined in vitro microcurrent stimulation and celecoxib suppress NF-κB/NLRP3 signaling and cartilage catabolism in human chondrocytes. Immunologic Research. https://doi.org/10.1007/s12026-026-09847-2

Vrouva, S., Chanopoulos, K., Andreou, E., Stamou, M., & Koumantakis, G. A. (2026). Transcutaneous Electrical Nerve Stimulation (TENS) Versus Microcurrent Electrical Neuromuscular Stimulation (MENS) Combined with Kinesiotherapy in Partial-Thickness Rotator Cuff Tears: A 12-Month Randomized Controlled Trial. Healthcare, 14(19), 3290. https://doi.org/10.3390/healthcare14193290